GENTEX CORPORATION (GNTX) FY2026 Q2 Statement of Cash Flows

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
GENTEX CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income from consolidated operations → Net cash from operating activities: $114,183,771.00Accounts receivable, net → Operating adjustments reconciliation: $33,129,961.00Depreciation and amortization → Operating adjustments reconciliation: $25,773,929.00Prepaid expenses and other → Operating adjustments reconciliation: $17,087,359.00Stock-based compensation expense related to employee stock options, employee stock purchases and restricted stock → Operating adjustments reconciliation: $9,733,390.00Impairment charges - investments → Operating adjustments reconciliation: $9,423,773.00Inventories → Operating adjustments reconciliation: $4,559,195.00Reserve for credit losses → Operating adjustments reconciliation: $2,882,691.00Loss on sale of investments and technology investment losses → Operating adjustments reconciliation: $1,128,262.00Loss on disposal of assets → Operating adjustments reconciliation: $7,206.00Operating adjustments reconciliation → Net cash from operating activities: $70,396,680.00Operating adjustments reconciliation → Accounts payable: $22,924,776.00Operating adjustments reconciliation → Accrued liabilities, excluding dividends declared: $4,537,007.00Operating adjustments reconciliation → Deferred income taxes: $3,081,221.00Operating adjustments reconciliation → Gain on disposal of assets: $1,854,931.00Operating adjustments reconciliation → Gain on sale of investments and technology investment income: $931,151.00Purchase of equity method investments → investing reconciliation: $1,456,205.00Sales proceeds → investing reconciliation: $1,371,014.00Maturities and calls → investing reconciliation: $1,000,000.00Proceeds from sale of plant and equipment → investing reconciliation: $371,925.00investing reconciliation → Plant and equipment additions: $19,195,275.00investing reconciliation → Decrease (increase) in other assets: $3,980,969.00investing reconciliation → Loans to technology investment partners: $3,602,372.00investing reconciliation → Purchases: $441,043.00Net cash used in financing activities → financing reconciliation: $92,877,340.00Issuance of common stock from stock plan transactions → financing reconciliation: $1,909,031.00financing reconciliation → Repurchases of common stock: $69,229,782.00financing reconciliation → Cash dividends paid: $25,556,589.00Net cash used in investing activities → investing reconciliation: $23,020,515.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $164,761,633.00Net cash from operating activities → Cash sources and uses: $184,580,451.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $233,444,229.00Cash sources and uses → Net cash used in investing activities: $23,020,515.00Cash sources and uses → Net cash used in financing activities: $92,877,340.00Net income from consolidated operations: $114,183,771.00Net income from consolidated operations+$114.18 MDepreciation and amortization: $25,773,929.00Depreciation & amortization+$25.77 MGain on disposal of assets: -$1,854,931.00Gain on disposal of assets−$1.85 MLoss on disposal of assets: $7,206.00Loss on disposal of assets+$7.21 KGain on sale of investments and technology investment income: -$931,151.00Gain on investment sales−$931.15 KLoss on sale of investments and technology investment losses: $1,128,262.00Investment sale losses+$1.13 MDeferred income taxes: -$3,081,221.00Deferred income taxes−$3.08 MStock-based compensation expense related to employee stock options, employee stock purchases and restricted stock: $9,733,390.00Stock-based compensation+$9.73 MImpairment charges - investments: $9,423,773.00Equity-method impairment+$9.42 MAccounts receivable, net: $33,129,961.00Accounts receivable+$33.13 MInventories: $4,559,195.00Inventories+$4.56 MPrepaid expenses and other: $17,087,359.00Prepaid & other assets+$17.09 MAccounts payable: -$22,924,776.00Accounts payable−$22.92 MAccrued liabilities, excluding dividends declared: -$4,537,007.00Accrued liabilities−$4.54 MReserve for credit losses: $2,882,691.00Loan & lease loss provision+$2.88 MImpairment charges - intangible assets: $0.00Net cash from operating activities: $184,580,451.00Operating cash+$184.58 MOperating adjustments reconciliation: $103,725,766.00Issuance of common stock from stock plan transactions: $1,909,031.00Common stock issued+$1.91 MCash dividends paid: -$25,556,589.00Common dividends paid−$25.56 MRepurchases of common stock: -$69,229,782.00Common stock repurchases−$69.23 MNet cash used in financing activities: -$92,877,340.00. Cash required to fund net payments.Financing cash−$92.88 Mfinancing reconciliation: $94,786,371.00Sales proceeds: $1,371,014.00AFS securities sales+$1.37 MPurchases: -$441,043.00AFS securities purchases−$441.04 KPlant and equipment additions: -$19,195,275.00Capital expenditures−$19.20 MProceeds from sale of plant and equipment: $371,925.00PP&E sales+$371.93 KDecrease (increase) in other assets: -$3,980,969.00Other assets−$3.98 MLoans to technology investment partners: -$3,602,372.00Loans to related parties−$3.60 MPurchase of equity method investments: $1,456,205.00Equity-method investments made+$1.46 MAcquisition of businesses, net of cash acquired: $0.00Maturities and calls: $1,000,000.00AFS securities maturities+$1.00 MNet cash used in investing activities: -$23,020,515.00. Cash required to fund net payments.Investing cash−$23.02 Minvesting reconciliation: $27,219,659.00Cash sources and uses: $349,342,084.00Beginning cash: Cash, cash equivalents, and restricted cash: $164,761,633.00Beginning cash$164.76 MEnding cash: Cash, cash equivalents, and restricted cash: $233,444,229.00Ending cash$233.44 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$165.39 MOperating cash − cash spent on productive assetsCash flow / Net income1.62×Operating cash flow ÷ net incomeNet cash change+$68.68 MEnding cash − beginning cash
Chart details

GENTEX CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
164,761,633 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
184,580,451 US dollars. Net cash provided.
Net income from consolidated operations
114,183,771 US dollars
Depreciation and amortization
25,773,929 US dollars
Gain on disposal of assets
negative 1,854,931 US dollars
Loss on disposal of assets
7,206 US dollars
Gain on sale of investments and technology investment income
negative 931,151 US dollars
Loss on sale of investments and technology investment losses
1,128,262 US dollars
Deferred income taxes
negative 3,081,221 US dollars
Stock-based compensation expense related to employee stock options, employee stock purchases and restricted stock
9,733,390 US dollars
Impairment charges - investments
9,423,773 US dollars
Accounts receivable, net
33,129,961 US dollars
Inventories
4,559,195 US dollars
Prepaid expenses and other
17,087,359 US dollars
Accounts payable
negative 22,924,776 US dollars
Accrued liabilities, excluding dividends declared
negative 4,537,007 US dollars
Reserve for credit losses
2,882,691 US dollars
Impairment charges - intangible assets
0 US dollars
Investing activities
negative 23,020,515 US dollars. Net cash used.
Sales proceeds
1,371,014 US dollars
Purchases
negative 441,043 US dollars
Plant and equipment additions
negative 19,195,275 US dollars
Proceeds from sale of plant and equipment
371,925 US dollars
Decrease (increase) in other assets
negative 3,980,969 US dollars
Loans to technology investment partners
negative 3,602,372 US dollars
Purchase of equity method investments
1,456,205 US dollars
Acquisition of businesses, net of cash acquired
0 US dollars
Maturities and calls
1,000,000 US dollars
Financing activities
negative 92,877,340 US dollars. Net cash used.
Issuance of common stock from stock plan transactions
1,909,031 US dollars
Cash dividends paid
negative 25,556,589 US dollars
Repurchases of common stock
negative 69,229,782 US dollars
Operating adjustment reconciliation
103,725,766 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
94,786,371 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
27,219,659 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
233,444,229 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
349,342,084 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
68,682,596 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.62×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
184,580,451 US dollars. Operating cash flow used in the free cash flow calculation.
cash spent on productive assets
19,195,275 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
165,385,176 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $70.40M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash spent on productive assets equals free cash flow: 184,580,451 US dollars minus 19,195,275 US dollars equals 165,385,176 US dollars.
GENTEX CORPORATION (GNTX) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!